A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod (Systematic Evaluation of Aspirin and Fish Oil) polyp prevention trial
Latest Information Update: 26 Aug 2024
At a glance
- Drugs Eicosapentaenoic acid (Primary) ; Aspirin
- Indications Adenoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms seAFOod Polyp Prevention Trial
Most Recent Events
- 01 Aug 2024 Results of secondary analysis published in the American Journal of Clinical Nutrition.
- 30 Jul 2023 Results published in the Alimentary Pharmacology and Therapeutics
- 30 Nov 2018 Results published in the Lancet